(Q44032593)

29 November 2017

title

Cytochrome P450 enzymes contributing to demethylation of maprotiline in man. (English)

1 reference

29 November 2017

Lars Brachtendorf

1

1 reference

29 November 2017

Alexander Jetter

2

1 reference

29 November 2017

K Tobias Beckurts

3

1 reference

29 November 2017

Arnulf H Hölscher

4

1 reference

29 November 2017

Uwe Fuhr

5

1 reference

29 November 2017

publication date

1 March 2002

1 reference

Basic and Clinical Pharmacology and Toxicology

29 November 2017

published in

1 reference

29 November 2017

volume

90

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

144-149

1 reference

A new look at the statistical model identification

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Clinical pharmacokinetics of fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Neurobiochemical Aspects of Maprotiline (Ludiomil®) Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Statistical estimations in pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Maprotiline metabolism appears to co-segregate with the genetically-determined CYP2D6 polymorphic hydroxylation of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Comparisons of Maprotiline with Imipramine in Severe Depression: A Multicenter Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

Bioavailability and kinetics of maprotiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Pharmacogenetics of antidepressants: clinical aspects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Isolation and identification of hydroxylated maprotiline metabolites

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Characterization of inducible nitric-oxide synthase by cytochrome P-450 substrates and inhibitors. Inhibition by chlorzoxazone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900306.X

7 January 2021

10.1034/J.1600-0773.2002.900306.X

Identifiers

DOI

1 reference

29 November 2017

1 reference